Neurotrophic Natural Products
© 2024. The Author(s), under exclusive license to Springer Nature Switzerland AG..
Neurotrophins (NGF, BDNF, NT3, NT4) can decrease cell death, induce differentiation, as well as sustain the structure and function of neurons, which make them promising therapeutic agents for the treatment of neurodegenerative disorders. However, neurotrophins have not been very effective in clinical trials mostly because they cannot pass through the blood-brain barrier owing to being high-molecular-weight proteins. Thus, neurotrophin-mimic small molecules, which stimulate the synthesis of endogenous neurotrophins or enhance neurotrophic actions, may serve as promising alternatives to neurotrophins. Small-molecular-weight natural products, which have been used in dietary functional foods or in traditional medicines over the course of human history, have a great potential for the development of new therapeutic agents against neurodegenerative diseases such as Alzheimer's disease. In this contribution, a variety of natural products possessing neurotrophic properties such as neurogenesis, neurite outgrowth promotion (neuritogenesis), and neuroprotection are described, and a focus is made on the chemistry and biology of several neurotrophic natural products.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:123 |
|---|---|
| Enthalten in: |
Progress in the chemistry of organic natural products - 123(2024) vom: 09., Seite 1-473 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Fukuyama, Yoshiyasu [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 14.02.2024 Date Revised 14.02.2024 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1007/978-3-031-42422-9_1 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM368297934 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM368297934 | ||
| 003 | DE-627 | ||
| 005 | 20240214233334.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240211s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/978-3-031-42422-9_1 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1293.xml |
| 035 | |a (DE-627)NLM368297934 | ||
| 035 | |a (NLM)38340248 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Fukuyama, Yoshiyasu |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Neurotrophic Natural Products |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 14.02.2024 | ||
| 500 | |a Date Revised 14.02.2024 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2024. The Author(s), under exclusive license to Springer Nature Switzerland AG. | ||
| 520 | |a Neurotrophins (NGF, BDNF, NT3, NT4) can decrease cell death, induce differentiation, as well as sustain the structure and function of neurons, which make them promising therapeutic agents for the treatment of neurodegenerative disorders. However, neurotrophins have not been very effective in clinical trials mostly because they cannot pass through the blood-brain barrier owing to being high-molecular-weight proteins. Thus, neurotrophin-mimic small molecules, which stimulate the synthesis of endogenous neurotrophins or enhance neurotrophic actions, may serve as promising alternatives to neurotrophins. Small-molecular-weight natural products, which have been used in dietary functional foods or in traditional medicines over the course of human history, have a great potential for the development of new therapeutic agents against neurodegenerative diseases such as Alzheimer's disease. In this contribution, a variety of natural products possessing neurotrophic properties such as neurogenesis, neurite outgrowth promotion (neuritogenesis), and neuroprotection are described, and a focus is made on the chemistry and biology of several neurotrophic natural products | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Chemical synthesis | |
| 650 | 4 | |a Natural products | |
| 650 | 4 | |a Neurite outgrowth | |
| 650 | 4 | |a Neurogenesis | |
| 650 | 4 | |a Neuroprotective | |
| 650 | 4 | |a Neurotrophic activity | |
| 650 | 4 | |a Neurotrophin | |
| 650 | 4 | |a Neurotrophin mimetics | |
| 650 | 4 | |a PC12 cells | |
| 650 | 7 | |a Biological Products |2 NLM | |
| 650 | 7 | |a Nerve Growth Factors |2 NLM | |
| 700 | 1 | |a Kubo, Miwa |e verfasserin |4 aut | |
| 700 | 1 | |a Harada, Kenichi |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Progress in the chemistry of organic natural products |d 2017 |g 123(2024) vom: 09., Seite 1-473 |w (DE-627)NLM368297926 |x 2191-7043 |7 nnns |
| 773 | 1 | 8 | |g volume:123 |g year:2024 |g day:09 |g pages:1-473 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/978-3-031-42422-9_1 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 123 |j 2024 |b 09 |h 1-473 | ||